ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue223,807124,90117,33161
Cost of Revenue205,493162,249103,69076,369
Gross Profit18,314-37,348-86,359-76,308
Operating Expenses
Research Development-149,189149,189149,189
Selling General and Administrative265,758255,062186,45678,704
Non Recurring----
Others----
Total Operating Expenses471,251417,311290,146155,073
Operating Income or Loss-247,444-292,410-272,815-155,012
Income from Continuing Operations
Total Other Income/Expenses Net3,5084,1262,763-9,101
Earnings Before Interest and Taxes-247,444-292,410-272,815-155,012
Interest Expense----
Income Before Tax-243,936-288,284-270,052-164,113
Income Tax Expense1,2561,1191,341330
Minority Interest----
Net Income From Continuing Ops-245,192-289,403-271,393-164,443
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-245,192-289,403-271,393-164,443
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-245,192-289,403-271,393-164,443